The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sumer Jacquelyn L since 2022.
This trader's CIK number is 1844824.
At the time of last reporting, Sumer Jacquelyn L was the Chief Legal Officer of Cullinan Therapeutics, Inc.. (stock ticker symbol CGEM).
Also see all insider trading activities at Cullinan Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CGEM | 0 | $0 | 3,482 | $39,729 | 0 | $0 |
| 2023 | CGEM | 0 | $0 | 2,867 | $27,154 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | GNCA | 0 | $0 | 2,500 | $150 | 0 | $0 |
1. Cullinan Therapeutics, Inc. (CGEM)
2. Genocea Biosciences, Inc. (GNCA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-18 | CGEM | Sale | 3,482 | 11.41 | 39,729 |
| 2023-12-21 | CGEM | Sale | 1,400 | 8.50 | 11,900 |
| 2023-12-18 | CGEM | Sale | 290 | 8.22 | 2,383 |
| 2023-06-20 | CGEM | Sale | 291 | 12.94 | 3,765 |
| 2023-05-18 | CGEM | Sale | 291 | 8.76 | 2,549 |
| 2023-04-18 | CGEM | Sale | 290 | 10.71 | 3,105 |
| 2023-03-20 | CGEM | Sale | 305 | 11.32 | 3,452 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-01 | GNCA | Sale | 2,500 | .06 | 150 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sumer Jacquelyn L (Chief Legal Officer of Cullinan Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.